Qulipta 30 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FZX43
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,240
Award facts
- Contract value 100% obligated
- $1,240.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,240.32 to DMS Pharmaceutical Group Inc. for the supply of Qulipta 30 mg tablets (30-count units). Issued on July 22, 2025, with an ultimate completion date of July 23, 2025, this firm fixed-price delivery order represents a pharmaceutical supply procurement under DLA's medical logistics operations. The award carries no set-aside designation, and performance will be executed in Park Ridge, Illinois, where the vendor is headquartered.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program valued at $499,999,999 through November 2026. This delivery order was issued under that overarching IDC framework, which enables the DLA to procure a comprehensive portfolio of pharmaceutical products to support Department of Defense healthcare facilities worldwide. As a registered federal contractor since 2001, DMS Pharmaceutical Group has established itself as a key supplier in the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and medical consumables to military health facilities across the nation.
Quick answers
Who was awarded contract SPE2DB25FZX43?
SPE2DB25FZX43 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FZX43 worth?
The government has obligated $1,240 on SPE2DB25FZX43.
Is contract SPE2DB25FZX43 an order under another contract?
Yes. SPE2DB25FZX43 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX43 competed?
The extent of competition for SPE2DB25FZX43 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award